Asia On The Move: Personnel News From Shanghai Pharma, Daiichi Sankyo, Merck Serono, Mindray, GSK
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharma has a new CEO after a large shakeup, and GSK appoints an interim head of discovery in China after Nature Medicine fallout. Mindray returns to co-CEO model, and personnel changes occur at Astellas, Merck Serono, Daiichi Sankyo and RDPAC.